Displaying all 10 drugs
Lutetium Lu 177 dotatate
A 177Lu-labeled somatostatin analog peptide, Lutetium Lu 177 dotatate belongs to an emerging form of treatments called Peptide Receptor Radionuclide Therapy (PRRT), which involves targeting tumours with molecules carrying radioactive particles that bind to specific receptors expressed by the tumour. Lutetium Lu 177 dotatate may also be referred to as...
Approved
Investigational
Matched Synonyms: … Lutetium dotatate Lu-177 ... lutetium Lu 177 dotatate ... Lutetium oxodotreotide Lu-177 …
Matched Name: … Lutetium Lu 177 dotatate …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(1S,2R)-1-carboxy- …
Matched Description: … Lutetium Lu 177 dotatate may also be referred to as 177Lu-DOTA-Tyr3-octreotate. ... A 177Lu-labeled somatostatin analog peptide, Lutetium Lu 177 dotatate belongs to an emerging form of ... Compared to the alternative somatostatin analogue DOTA-Tyr3-octreotide (dotatoc), Lutetium Lu 177 dotatate …
Matched Categories: … Lutetium …
Matched Name: … Lutetium Lu 177 dotatate …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(1S,2R)-1-carboxy- …
Matched Description: … Lutetium Lu 177 dotatate may also be referred to as 177Lu-DOTA-Tyr3-octreotate. ... A 177Lu-labeled somatostatin analog peptide, Lutetium Lu 177 dotatate belongs to an emerging form of ... Compared to the alternative somatostatin analogue DOTA-Tyr3-octreotide (dotatoc), Lutetium Lu 177 dotatate …
Matched Categories: … Lutetium …
Lutetium Lu-177
Approved
Matched Synonyms: … Lutetium-177 …
Matched Name: … Lutetium Lu-177 …
Matched Iupac: … (177Lu)lutetium …
Matched Salts name: … Lutetium chloride Lu-177 …
Matched Name: … Lutetium Lu-177 …
Matched Iupac: … (177Lu)lutetium …
Matched Salts name: … Lutetium chloride Lu-177 …
Lutetium Lu-177 vipivotide tetraxetan
Lutetium Lu-177 vipivotide tetraxetan is a radioligand therapeutic agent. It consists of a radionuclide, lutetium Lu-177, linked to a moiety that binds to PSMA, a transmembrane protein that is expressed in prostate cancer. Lutetium Lu-177 vipivotide tetraxetan was first approved by the FDA on March 23, 2022 as a treatment...
Approved
Matched Name: … Lutetium Lu-177 vipivotide tetraxetan …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4,7-bis(carboxylatomethyl)-10-[({[(1r,4r)-4-{[(1S)-1-{[(5S)-5-carboxy-5-({[(1S …
Matched Description: … Lutetium Lu-177 vipivotide tetraxetan is a radioligand therapeutic agent. ... [L43787] In December 2022, lutetium Lu-177 vipivotide tetraxetan was approved by the EMA. ... It consists of a radionuclide, [lutetium Lu-177], linked to a moiety that binds to PSMA, a transmembrane …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4,7-bis(carboxylatomethyl)-10-[({[(1r,4r)-4-{[(1S)-1-{[(5S)-5-carboxy-5-({[(1S …
Matched Description: … Lutetium Lu-177 vipivotide tetraxetan is a radioligand therapeutic agent. ... [L43787] In December 2022, lutetium Lu-177 vipivotide tetraxetan was approved by the EMA. ... It consists of a radionuclide, [lutetium Lu-177], linked to a moiety that binds to PSMA, a transmembrane …
Lutetium Lu177 Edotreotide
Investigational
Matched Synonyms: … Edotreotide lutetium Lu-177 ... Lutetium (177lu) edotreotide ... Lutetium lu 177-edotreotide …
Matched Name: … Lutetium Lu177 Edotreotide …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(2R,3R)-1,3-dihydroxybutan …
Matched Name: … Lutetium Lu177 Edotreotide …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(2R,3R)-1,3-dihydroxybutan …
Motexafin lutetium
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Matched Synonyms: … Lutetium texaphyrin anhydrous ... Motexafin lutetium anhydrous …
Matched Name: … Motexafin lutetium …
Matched Iupac: … lutetium(3+) 4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis({2-[2-(2-methoxyethoxy)ethoxy]ethoxy})-10,23 …
Matched Description: … Also called lutetium texaphyrin. ... Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer ... Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties. …
Matched Salts name: … Motexafin lutetium hydrate …
Matched Name: … Motexafin lutetium …
Matched Iupac: … lutetium(3+) 4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis({2-[2-(2-methoxyethoxy)ethoxy]ethoxy})-10,23 …
Matched Description: … Also called lutetium texaphyrin. ... Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer ... Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties. …
Matched Salts name: … Motexafin lutetium hydrate …
PP-F11N lutetium Lu-177
Investigational
Matched Synonyms: … Lutetium lu 177 pp-f11n …
Matched Name: … PP-F11N lutetium Lu-177 …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1S)-1-{[(1S)-1-[({ …
Matched Name: … PP-F11N lutetium Lu-177 …
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1S)-1-{[(1S)-1-[({ …
Zalsenertant tetraxetan lutetium Lu-177
Investigational
Matched Synonyms: … Lutetium Lu 177 DOTA-3BP-227 ... Lutetium Lu 177 DOTA-IPN01087 ... Lutetium Lu 177 zalsenertant tetraxetan …
Matched Name: … Zalsenertant tetraxetan lutetium Lu-177 …
Matched Name: … Zalsenertant tetraxetan lutetium Lu-177 …
RAD 502
Investigational
Matched Synonyms: … Lutetium-177 labeled humanized monoclonal antibody targeting leucine rich repeat containing 15 (LRRC15 …
Gallium Ga-68 gozetotide
Gallium (Ga) 68 prostate-specific membrane antigen (PSMA)-11, or Ga-68 gozetotide, is a radiopharmaceutical agent used to identify and assess prostate-specific membrane antigen (PSMA)-positive lesions in adult men with prostate cancer during positron emission tomography (PET). Prostate cancer is one of the most commonly diagnosed cancers among men in Western countries...
Approved
Tetulomab tetraxetan Lu-177
Betalutin has been used in trials studying the treatment of Non-Hodgkin Lymphoma and Relapsed, Diffuse Large B-cell Lymphoma.
Investigational
Matched Categories: … Lutetium …
Displaying all 10 drugs